CONVERSION FROM INTRAVENOUS PROCAINAMIDE TO ORAL SUSTAINED-RELEASE TABLETS IN CARDIAC PATIENTS

被引：0
|
作者：
KALIN, ML [1 ]
BABICH, MF [1 ]
KLINKE, WP [1 ]
HUI, WK [1 ]
机构：
[1] ROYAL ALEXANDRA HOSP,DEPT CARDIOL,10240 KINGSWAY AVE,EDMONTON T5H 3V9,ALBERTA,CANADA
来源：
CANADIAN JOURNAL OF CARDIOLOGY | 1990年 / 6卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：15 / 18
页数：4
相关论文
共 50 条
  • [1] CONVERSION FROM INTRAVENOUS TO ORAL DOSING USING SUSTAINED-RELEASE THEOPHYLLINE TABLETS
    STEIN, GE
    HAUGHEY, DB
    ROSS, RJ
    VAKOUTIS, J
    [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1982, 16 (10): : 772 - 774
  • [2] MALABSORPTION OF SUSTAINED-RELEASE PROCAINAMIDE TABLETS
    GAL, P
    HASSPACHER, JB
    MCCUE, JD
    INGRAM, RG
    [J]. SOUTHERN MEDICAL JOURNAL, 1982, 75 (09) : 1158 - 1159
  • [3] CONVERSION FROM INTRAVENOUS TO SUSTAINED-RELEASE ORAL THEOPHYLLINE IN PEDIATRIC-PATIENTS WITH ASTHMA
    CLARKE, DF
    WERBOWSKY, OL
    GRODIN, MA
    SHARGEL, L
    [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1986, 20 (09): : 700 - 703
  • [4] KINETICS AND BIOAVAILABILITY OF PROCAINAMIDE - COMPARISON OF ORAL PROCAINAMIDE (USP) AND SUSTAINED-RELEASE PROCAINAMIDE
    NIEUWOUDT, C
    DAVIS, R
    FISHER, M
    LESKO, L
    [J]. CLINICAL RESEARCH, 1983, 31 (02): : A252 - A252
  • [5] COMPUTER-SIMULATED CONVERSION FROM INTRAVENOUS TO SUSTAINED-RELEASE ORAL THEOPHYLLINE
    IAFRATE, RP
    GOTZ, VP
    ROBINSON, JD
    LUPKIEWICZ, SM
    [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1982, 16 (01): : 19 - 25
  • [6] DOSAGE, PLASMA CONCENTRATION AND ANTIARRHYTHMIC EFFECT OF PROCAINAMIDE IN SUSTAINED-RELEASE TABLETS
    ARSTILA, M
    KATILA, M
    SUNDQUIST, H
    ANTTILA, M
    PERE, E
    TIKKANEN, R
    [J]. ACTA MEDICA SCANDINAVICA, 1974, 195 (03): : 217 - 222
  • [7] BIOEQUIVALENCY OF SUSTAINED-RELEASE PROCAINAMIDE
    HULL, RL
    [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1984, 18 (06): : 530 - 531
  • [8] SUSTAINED-RELEASE PROCAINAMIDE AND NEUTROPENIA
    ANDERSON, S
    WENGER, NK
    [J]. ANNALS OF INTERNAL MEDICINE, 1984, 101 (03) : 404 - 404
  • [9] THE DESIGN OF ORAL SUSTAINED-RELEASE THEOPHYLLINE DOSING AFTER CONVERSION FROM INTRAVENOUS TO ORAL-THERAPY
    YAMAZAKI, M
    FUKUTOMI, O
    KONDO, N
    KATO, Z
    NAKASHIMA, Y
    SHINODA, S
    AGATA, H
    KONDO, T
    IMAEDA, N
    ORII, T
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1994, 32 (11) : 625 - 631
  • [10] COMPARATIVE BIOAVAILABILITY OF 2 ORAL SUSTAINED-RELEASE PROCAINAMIDE PRODUCTS
    BAKER, BA
    REYNOLDS, JR
    GLECKEL, L
    AZARY, E
    BODENHEIMER, MM
    [J]. CLINICAL PHARMACY, 1988, 7 (02): : 135 - 138
12345